Bologna Presidents: Robin Foà Pier Luigi Zinzani
Under the auspices of: DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE - ALMA MATER STUDIORUM UNIVERSITÀ DI BOLOGNA Monday, November 13, 9.00 am AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA AIL - ASSOCIAZIONE ITALIANA CONTRO LE LEUCEMIE-LINFOMI E MIELOMA - SEZIONE DI BOLOGNA Session I REGIONE EMILIA-ROMAGNA Welcome and Introduction R. Foà, P.L. Zinzani Genomic Landscapes Chairmen: N. Chiorazzi, G. Gaidano pathogenesis: a cooperation between microenviroments and genetics C.M. Croce 9.30 am 9.15 am Jennifer R. Brown Boston, USA Jan A. Burger Houston, USA Nicholas Chiorazzi New York, USA Carlo M. Croce Columbus, USA Antonio Cuneo Ferrara, Italy Barbara Eichhorst Köln, Germany Robin Foà Rome, Italy Gianluca Gaidano Novara, Italy Paolo Ghia Milan, Italy Peter Hillmen Leeds, United Kingdom Michael J. Keating Houston, USA Emilio Montserrat Barcelona, Spain Susan M. O Brien Orange, USA Davide Rossi Bellinzona, Switzterland Constantine Tam Melbourne, Australia Pier Luigi Zinzani Italy 9.45 am Genetic portrait of N. Chiorazzi 10.00 am 10.15 am Predictive biomarkers D. Rossi 10.30 am 10.45 am Coffee break 3
Monday, November 13, Session II Session III Chairman: R. Foà Chairmen: P. Ghia, E. Montserrat Chemoimmunotherapy Novel Targeted Therapies FCR M.J. Keating Ibrutinib J.A. Burger 11.00 am 11.15 am 2.00 pm 2.15 pm BR B. Eichhorst 11.30 am 11.45 am Chlorambucil plus anti-cd20 MoAb 12.00 pm 12.15 pm Round Table B. Eichhorst,, M.J. Keating 12.30 pm 13.00 pm 2.30 pm Idelalisib 2.45 pm Venetoclax 3.00 pm 3.15 pm 3.30-4.30 pm Round Table J.A. Burger,, Lunch 4 5
Tuesday, November 14, Session IV Session V Chairmen: J.R. Brown, P.L. Zinzani Chairmen: J.A. Burger, A. Cuneo Newer Agents 8.30 am Next-generation BTK inhibitors: - Acalabrutinib Interesting Questions Is it possible to stop treatment with the new targeted therapies? 10.30 am J.R. Brown - BGB-3111 C. Tam 9.00 am 9.15 am Other PI3K inhibitors: - Duvelisib - TGR-1202 11.00 am Are there advances with combinations of therapies using targeted agents? J.A. Burger 11.15 am 11.30 am Which is the best sequence of these novel agents? S.M. O Brien 10.45 am - Pilaralisib J.R. Brown 10.00 am 10.15 am Coffee break 6 11.45 am 12.00 pm Arrivederci 7
With an unrestricted educational grant of: GENERAL INFORMATION Meeting Venue Via Montebello, 8 40121 Italy Phone: +39 051 249361 - Fax: +39 051 249724 www.royalhotelcarltonbologna.com Official Language English. Slides Slides must be in English. Computer videoprojection will be available in Power Point. Other requirements should be communicated to the Organizing Secretariat as soon as possible. Slides should be handed to the slide center one hour before the beginning of the session and collected at the end. Badge All registered participants and speakers will be given a badge which they must wear to be admitted to the scientific sessions. Attendance certificate A certificate will be given to all participants at the end of the meeting. CME An application for Italian CME credits have been made as follows: - Provider Studio ER Congressi SRL: ID 828-197202 - No.10 CME credits for physicians (disciplines: Hematology, Oncology, Radiotherapy) - Educational objective: guidelines-protocols-procedures. Changes Parts of the program may be changed without notice. Organizing Secretariat Studio E.R. Congressi Via Marconi, 36-40122 Bologna Phone: +39 051 4210559 - Fax: +39 051 4210174 E-mail: ercongressi@ercongressi.it www.ercongressi.it project: struchel.com